Exchange Transfusion

PROCEDURE2 trials

Sponsors

Columbia University

Conditions

Anemia, Sickle CellSickling Disorder Due to Hemoglobin S

Phase 1

Siplizumab for Sickle Cell Disease Transplant

TerminatedNCT06078696

Columbia UniversityAnemia, Sickle Cell

Start: 2023-09-28End: 2025-12-11Updated: 2026-02-27

131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

RecruitingNCT07015684

Columbia UniversitySickling Disorder Due to Hemoglobin S

Start: 2025-04-28End: 2032-03-12Target: 24Updated: 2025-06-11